Theranexus SA (PA:ALTHX) — Stock Price

€4.58 EUR
▲ 0.00% today

Theranexus SA (PA:ALTHX) is currently trading at €4.58 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €1.57 and €4.59. This page tracks Theranexus SA's live share price on the PA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see ALTHX market cap overview.

Theranexus SA (ALTHX) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Theranexus SA's daily closing share price and trading volume on the PA exchange over the past year, giving a clear view of recent price momentum and liquidity.

Theranexus SA Income Statement — Revenue, Profit & Earnings by Year

Theranexus SA's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue €0.00 €2.28 Million €296.33K €414.90K €602.00
Cost of Revenue €108.60K €2.62 Million €4.94 Million €332.00K €8.82 Million
Gross Profit €-108.60K €-333.55K €-4.64 Million €82.90K €-8.82 Million
Research & Development €861.00K €2.67 Million €7.54 Million €3.92 Million €5.55 Million
SG&A €2.09 Million €2.60 Million €7.02 Million €590.83K
Total Operating Expenses €10.12 Million €2.29 Million €3.00 Million €5.92 Million €690.24K
Operating Income €-10.23 Million €-4.81 Million €-7.64 Million €-6.26 Million €-9.51 Million
EBITDA €-10.12 Million €-2.53 Million €-7.39 Million €-5.93 Million €-8.67 Million
EBIT €-10.23 Million €-2.63 Million €-7.64 Million €-6.26 Million €-9.88 Million
Interest Expense €99.42K €152.86K €83.97K €158.00K €33.20K
Income Before Tax €-4.00 Million €-2.53 Million €-7.63 Million €-7.19 Million €-9.91 Million
Income Tax Expense €-998.03K €768.08K €-801.84K €-619.00K €-1.76 Million
Net Income €-3.00 Million €-1.77 Million €-6.83 Million €-6.57 Million €-8.15 Million

Theranexus SA Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Theranexus SA's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets €10.54 Million €3.74 Million €7.24 Million €12.05 Million €16.89 Million
Total Current Assets €9.22 Million €2.58 Million €5.97 Million €10.53 Million €15.02 Million
Cash & Equivalents €252.28K €3.71 Million €7.00 Million €7.01 Million
Short-term Investments €7.02 Million €252.28K €3.71 Million €7.00 Million €7.01 Million
Net Receivables €1.36 Million €582.07K €4.75K €18.44K €2.07 Million
Inventory €1.00 €415.32K
Property, Plant & Equipment €3.47K €5.79K €168.08K €419.12K
Goodwill
Total Liabilities €7.64 Million €5.40 Million €5.02 Million €6.33 Million €6.71 Million
Total Current Liabilities €5.93 Million €3.68 Million €2.56 Million €2.72 Million €1.34 Million
Long-term Debt €1.12 Million €1.72 Million €3.64 Million €4.89 Million €5.33 Million
Net Debt €2.14 Million €2.16 Million €2.44 Million €2.78 Million €-192.75K
Total Stockholder Equity €1.99 Million €-1.66 Million €2.22 Million €5.73 Million €8.72 Million
Retained Earnings €-5.31 Million €-1.77 Million €-6.83 Million €-6.57 Million €-8.15 Million

Theranexus SA Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Theranexus SA generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow €-883.76K €-3.37 Million €-6.36 Million €-5.37 Million €-6.25 Million
Capital Expenditures €56.05K €32.72K €43.61K €41.22K €150.62K
Free Cash Flow €-939.81K €-3.40 Million €-6.40 Million €-5.41 Million €-6.40 Million
Investing Cash Flow €-168.23K €77.04K €-61.11K €323.53K €-150.62K
Financing Cash Flow €7.85 Million €-646.42K €2.22 Million €1.63 Million €7.71 Million
Dividends Paid
Stock-Based Compensation
Depreciation €108.60K €96.22K €256.26K €332.00K €1.20 Million
Change in Cash €26.67K €-3.94 Million €-4.20 Million €3.59 Million €-3.19 Million

Theranexus SA Earnings History — EPS Actual vs. Analyst Estimates

Track Theranexus SA's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Sep 24, 2025 -0.11 0.00
Apr 29, 2025 -0.20 0.00
Sep 26, 2024 0.01 0.00
Apr 12, 2023 -1.31 0.00
Jul 12, 2022 -0.65
Apr 25, 2022 -1.62 0.00
Sep 30, 2021 -0.82 0.00
Apr 07, 2021 -0.42 -0.94 +55.32%